TPG is a leading global private investment firm with approximately $45 billion of capital under management across a family of funds. Since the firm’s founding in 1992, their investment philosophy has been to create value by investing in change - change created by industry trends, economic cycles or specific company circumstances. Their tradition of providing unique investment insight and value-added operating capabilities to companies undergoing change, as well as their comfort in dealing with complexity and distressed companies, differentiates them from many traditional private investment firms.
| Company | Date | Round | Size | Participants |
| Nodality | 8/06 | Series A | $1.54M | 2 |
| CardioDx | 7/06 | Series B | $19M | 3 |
| VLST Corporation | 6/06 | Series B | $55M | 7 |
| MacroGenics | 5/06 | Series C | $45M | 11 |
| Avidia | 5/06 | Series C | $43.8M | 7 |
| OnVantage | 1/06 | Series B | $18M | 4 |
| XDx | 1/06 | Unattributed | $26.5M | 7 |
| CloudShield Technologies | 10/05 | Unattributed | $10M | 4 |
| Five Prime Therapeutics | 2/05 | Unattributed | $45M | 10 |
| CoVi Technologies | 1/05 | Series B | $15M | 4 |
| Spotcast Communications | 4/00 | Unattributed | $7.5M | 2 |
